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Abstract 
Background: To compare Endoscopic Retrograde 
Cholangio Pancreatography (ERCP) sedation 
receiving propofol alone and with midazolam in 
terms of mean propofol dosage and mean recovery 
time.  
Methods: In this comparative study, patients 
undergoing therapeutic ERCP were divided into 
Group A (Propofol alone) and Group B (Propofol 
plus Midazolam). Mean propofol dose adjusted to 
weight and duration of procedure and mean recovery 
time was compared between the two groups.  
Results: There were 40 patients in each group; 
46.3% (n=37) males and 53.8% (n=43) females. 
According to ASA class stratification, 43% (n=34) 
patients were in ASA class I, 41% (n=33) patients in 
ASA class II and 16% (n=13) patients in ASA class 
III. The mean dose of propofol was not significantly 
different between the two groups; 276 ± 124 mg 
(Group A) vs. 290 ± 115 mg (Group B), p=0.58). The 
mean adjusted dose when adjusted to weight and 
duration of procedure also did not significantly 
differ; 0.08 ± 0.04 (Group A) vs. 0.07 ± 0.03 (Group B), 
p= 0.38). The recovery time was significantly better 
with propofol monotherapy; 12 ± 7 min (Group A) 
vs. 44 ± 13 min (Group B), p=0.0001). 
Conclusion: In comparison to sedation with 
propofol and midazolam in ERCP, recovery time 
from sedation is shorter with propofol monotherapy 
with no additional propofol dose requirement.  
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Introduction 
       Conscious sedation is effective for diagnostic and 
therapeutic endoscopy.1 In comparison to conventional 
sedation, propofol is increasingly being used for 
conscious sedation due to its short biologic half-life 
and better safety profile.2 Gastroenterologists are 
satisfied with propofol sedation, especially in 
advanced endoscopic procedures like ERCP and EUS.3 
Current data suggest that endoscopists directed 
propofol sedation has increased to over 80,000 
procedures.4 The common combination sedation 
regimens used during endoscopic procedures are 
propofol plus benzodiazepine and benzodiazepine 
plus an opioid.5 
According to the position statement by American 
Society of Gastroenterology (ASGE), non-
Anesthesiologist Administered propofol (NAAP) is 
defined as administration of propofol under the 
direction of a physician who has not been trained as an 
anesthesiologist. Nurse administered propofol (NAPS) 
is similar concept but uses propofol as monotherapy.6 
Propofol is used either alone or in combination with 
one or more traditional agents. European Society of 
Gastrointestinal Endoscopy and the European Society 
of Anaesthesiology Guidelines states that “There is no 
clear evidence that combining propofol with another 
drug leads to a decrease in adverse effects (Evidence 
level 1+)”.7 
  
Patients and Methods  
    The study was conducted at Centre for Liver and 
Digestive diseases (CLD) of Holy Family Hospital, 
Rawalpindi. Patients who underwent therapeutic 
ERCP, from October 2011 to March 2012, were 
included. The study design was a randomized 
controlled trial. In group “A” (n=40) patients were 
given propofol monotherapy for sedation during 
ERCP. In group “B”(n=40) patients were given 
propofol along with midazolam for sedation during 
ERCP.  Potential adverse events (hypotension, risk of 
deep sedation and possibility of intervention in form 
of airway maneuvers at place of procedure or 
involvement of anesthesiologist) were explained. The 
enrolled patients were required to be in ASA Class I, II 
and III (Table 1). Patients in ASA class IV, V, patient 
age < 18 years,pregnant women,inability to provide 
informed consent, patients with known allergy to the 
drugs used, were excluded . All the procedures were 
performed in either left lateral or prone position. 
During the procedure 0.9% NaCl solution was 
continuously infused through a 3 way connector. 
Oxygen was administered at the rate of 2-3L/min. The 
assisting non-anesthesiologist monitored chest 
movements, breathing patterns, depth of sedation and 
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level of pain. Full resuscitation equipment was 
available within the endoscopy unit. 
     In the propofol group (group A), a loading dose of 
40 mg (< 70 kg b.w.) or 60 mg (≥ 70 kg b.w.) was 
administered intravenously followed by repeated 
doses of 20 mg of propofol depending on perceived 
need for maintenance of conscious/ deep sedation 
(Table 2). In the propofol plus midazolam group 
(group B), sedation was induced by an intravenous 
bolus of 2.5 mg (< 70 kg b.w.) or 3.5 mg (≥ 70 kg b.w.) 
of midazolam.  
 
Table 1: American Society of Anesthesiologists 
patients stratification (ASA) 3 
Class Description 
I The patient is normal and healthy. 
II The patient has mild systemic disease that does not 
limit activities (e.g., controlled hypertension or 
controlled diabetes). 
III The patient has moderate or severe systemic 
disease that does not limit the activities (e.g., stable 
angina or diabetes). 
IV The patient has severe systemic disease that is a 
constant threat to life (e.g. severe congestive heart 
failure, end-stage renal failure). 
V The patient is morbid and is at a substantial risk of 
death within 24 hours (with or without a 
procedure). 
E Emergency status: in addition to indicating the 
underlying ASA status (I-V), any patient 
undergoing an emergency procedure is indicated 
by suffix ‘‘E.’’ 
    Procedure time was defined as duration of time in 
minutes between insertion and withdrawal of 
endoscope. Recovery time was defined as the duration 
of time in minutes from withdrawal of endoscope to a 
state when the patient was fully awake and 
conversant. The complications were entered as (1) 
absent, (2) Minor complications i.e. requiring bag mask 
ventilation (either directly or via an endotracheal tube) 
with subsequent recovery at the place of procedure, (3) 
major complication i.e. needing cardiopulmonary 
resuscitation and shifting to intensive care and or 
death. A p value ≤ 0.05 was regarded as statistically 
significant. 
 
Results 
  There were 46.3% (n=37) males and 53.8% (n=43) 
females. Mean dose of Propofol was 283 mg. Mean 
procedure time and recovery time was 69+ 31 and 28 + 
19 minutes respectively (Table 3).  Patients in both 
groups were comparable with respect to baseline 
characteristics (Table 4). There was no significant  
Table 2: Levels of Sedation And Anesthesia3 
 Minimal 
sedation 
(anxiolysis) 
 
Modrate 
sedation 
(conscious 
sedation) 
Deep 
sedation 
General 
anesth-
esia 
 
Responsivenes 
impaired 
Normal 
response 
to verbal 
stimulus 
 
 
 
Purposeful 
response 
to verbal 
or tactile 
stimulus 
 
Purposef
ul 
response 
after 
repeated 
or 
painful 
stimulus 
 
Unarou-
sable 
even 
with 
painful 
stimulus 
Airway Unaffected 
 
 
 
 
Interventi-
on not 
required 
Intervent
ion may 
be 
Required 
Intervent
ion often 
required 
Spontaneous 
Ventilation 
Unaffected 
 
 
 
Adequate May be 
inadequa
te 
Frequen-
tly  
Inadeq-
uate 
Cardiovasclar 
Function 
Unaffected Usually 
Maintain-
ed 
Usually 
maintain-
ed 
My be 
Impaired 
 
difference between two groups in terms of mean 
propofol dose; 276±124 mg (Group A) vs. 290±115 mg 
(Group B),(p=0.58). Mean propofol dose when 
adjusted to weight and duration of procedure was also 
not significantly different between the two groups; 
0.08±0.04 mg/kg/min (Group A) vs. 0.07±0.03 
mg/kg/min (Group B),( p= 0.38). The recovery time 
was significantly different between the two groups; 
12±7 min (Group A) vs. 44±13 min (Group B), 
(p=0.0001) (Table 5). 
    
Table 3: Baseline Characteristics of Patients (n=80) 
Parameter Mean ± SD 
Age (yrs) 49±17 
Weight (kg) 58.7±10.4 
BMI (kg/m2) 24.7±2.6 
Propofol Dose (mg) 283±119 
Adjusted  Propofol Dose 
(mg/kg/min) 
0.08±0.04 
Procedure Time 69±31 
Recovery Time 28±19 
     SD= Standard Deviation 
 
 There was no significant difference between two 
groups in terms of mean propofol dose; 276±124 mg 
(Group A) vs. 290±115 mg (Group B), p=0.58). Mean 
propofol dose when adjusted to weight and duration 
of procedure was also not significantly different 
between the two groups; 0.08±0.04 mg/kg/min 
(Group A) vs. 0.07±0.03 mg/kg/min (Group B), p= 
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0.38). The recovery time was significantly different 
between the two groups; 12±7 min (Group A) vs. 
44±13 min (Group B), p=0.0001) (Table 5]. 
 
Table 4: Baseline Characteristics of Groups 
 Group A 
(n=40) 
Propofol 
alone  
40 
Group B 
(n=40) 
Propofol plus 
Midazolam 
  
 
p- value 
Gender Males 
 
20 17  
 Females 20 23 
 
 
 
Age (yrs) 
 
 
 
 
 
 
 
52±16 46±18 0.12 
 Weight (kg) 
 
 
 
58.9±9.4 
 
58.4±11.4 0.81 
BMI (kg/m2) 24.85±2.35 24.45±2.88 0.50 
Procedure Time 
( ) 
64±30 73±31 0.2 
Table 5: Propofol dosages and recovery time 
 Group A 
 
Group B p- value 
Mean Propofol 
D  ( ) 
276±124 290±115 0.58 
Mean Adjusted 
  
 
0.08±0.04 0.07±0.03 0.34 
Recovery Time
 
12±7 44±13 0.0001 
 
Discussion 
    In studies comparing propofol sedation as 
monotherapy with propofol based sedative 
combination regimens, a reduction in procedure time 
and recovery time is seen in the propofol group. 9-11 In 
present study it was  hypothesized that despite the use 
of larger dosage; propofol monotherapy for 
endoscopic sedation might decrease the recovery time 
despite a larger dose requirement with negligible 
sedation related complications that shall be 
comparable to the conventional sedation. The results 
of present study confirms this hypothesis (mean 
propofol dosage Group A: 276±124mg vs. Group B: 
290±115mg, p=0.58). Similar results are seen in clinical 
trials comparing propofol monotherapy with 
conventional benzodiazepine based sedation.12-14 A 
number of studies have also compared propofol based 
combination regimens with conventional 
benzodiazepines and opioids based regimens.15-17 The 
safety of propofol is also demonstrated in high-risk 
elderly patients undergoing ERCP.18  
     We followed the study protocol adopted by Seiffert 
et al, where  mean dose of propofol was adjusted to 
weight and duration of procedure.19 In the original 
study by Seiffert et al, a mean dose of 0.25±0.13 
mg.min/kg propofol was used in group A (propofol 
alone) as compared to 0.20±0.09 mg.min/kg 
of propofol in group B (p < 0.01, plus additional 2.9± 
0.5 mg of midazolam). The mean dose of propofol 
adjusted to weight and duration of procedure was also 
similar between two groups (group A: 0.08±0.04 
mg/kg/min vs. Group B: 0.07±0.03 mg/kg/min, 
p=0.34). In RCT comparing propofol with an oral 
midazolam based propofol regimen, higher doses 
of propofol were required by patients 
receiving propofol alone as compared to those which 
received oral midazolam (7.5mg) along with propofol 
(512±238 mg vs. 330±223 mg respectively, p < 0.001). 
The higher doses of propofol required were not 
associated with any significant respiratory 
complication.20 In another double-blind, randomized 
controlled trial the mean difference in mean propofol 
dose requirement was 61 mg (95%CI 40-82 mg); 192 
mg (propofol alone) vs. 131 mg (combination group). 
Although the patients’ tolerance visual assessment 
scores were higher in patients receiving propofol 
based combination regimen (endoscopist,p = 0.002 and 
anesthetist,p = 0.001), still all the patients reported 
equivalent levels of satisfaction with both sedation 
regimens. 21  
     Various studies conclude that sedation with 
propofol monotherapy in comparison to propofol in 
ERCP is effective, safe and has a better recovery time.22 
The shorter recovery time with propofol is also 
documented with nurse administered propofol during 
ERCP.23 The recovery time with propofol in our study 
is also significantly different between two groups 
(propofol alone 12±7 min vs. propofol plus midazolam 
44±13 min, p=0.0001). In a recent prospective, 
randomized, double-blind study, Lee et al compared 
the BPS (propofol in combination with midazolam and 
fentanyl) and propofol mono sedation in 
therapeutic ERCP and EUS. No significant differences 
in sedation efficacy, safety, procedure outcomes, and 
complications were found between the two groups. 
The only significant exception was a better mean 
recovery time (13.4 ±6.24 min) in propofol mono-
sedation than (18.37±7.86 min) in Balanced Propofol 
Sedation, (p < 0.001).24 In the original study by Seiffert 
et al , the mean recovery time was significantly better 
with propofol alone (19±7min) 
vs. propofol plus midazolam (25±8 min), p < 0.05).19 
On the contrary, in a similar study during 
colonoscopy, patients receiving combination regimens 
were discharged earlier than those receiving propofol 
alone (median 13.0-14.7 versus 18.1 min, p < 0.01). The 
possible reason for might be higher dose of propofol 
used in patients receiving propofol alone and 
subsequent deeper sedation scores compared with 
combination therapy (both p < 0.001). Importantly, 
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there were no differences in vital signs or oxygen 
saturations among the two groups. There were no 
significant differences in pain or satisfaction among 
the study arms in the recovery area.24,25  
       
Conclusion 
With the advent of concept of non-anesthesiologist 
administered propofol,sedation with propofol as 
monotherapy can be seen as a simple and safe 
approach. 
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